In addition, tyrosine kinase inhibitors; Imatinib and sunitinib are made available free of charge to all patients with CD117-positive GIST through the GIPAP (Glivec International Patient Assistance Program). The gene discussed is KIT; the disease is gastrointestinal stromal tumor.